Association of a promoter variant in the inducible cyclooxygenase-2 gene (PTGS2) with type 2 diabetes mellitus in Pima Indians

Human Genetics

Volumn 113, Issue 5, 2003, Pages 377-381

  Konheim, Yasmine L ^a   Wolford, Johanna K ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Translational Genomics Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2;

ALLELE; AMERICAN INDIAN; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE COURSE; DNA FLANKING REGION; EXON; GENE ACTIVITY; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCATION; GENE SEQUENCE; GENETIC CODE; GENETIC LINKAGE; GENETIC MARKER; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ARIZONA; BASE SEQUENCE; CYCLOOXYGENASE 2; DIABETES MELLITUS, TYPE 2; DNA PRIMERS; ENZYME INDUCTION; EXONS; FEMALE; GENE FREQUENCY; GENES, DOMINANT; GENES, RECESSIVE; GENETIC MARKERS; HUMANS; INDIANS, NORTH AMERICAN; INTRONS; ISOENZYMES; MALE; MEMBRANE PROTEINS; NUCLEAR FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; VARIATION (GENETICS);

EID: 0141955279     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-003-1000-y     Document Type: Article

References (21)

1. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553
2. Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, Vidal H, Hanque B (2000) Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85:3338-3342
3. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102:42-47
4. Hanson RL, Ehm MG, Pettit DJ, Prochazka M, Thompson DB, Timberlake D, Foroud T, Kobes S, Baier L, Burns DK, Almasy L, Blangero J, Garvey WT, Bennett PH, Knowler WC (1998) An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet 63:1130-1138
5. Hla T, Neilson K (1992) Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 89:7384-7388
6. Knowler WC, Bennett PH, Hamman RF, Miller M (1978) Diabetes incidence and prevalence in Pima Indians: A 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 108:497-505
7. Luo C, Kallajoki M, Gross R, Mulari M, Teros T, Ylinen L, Makinen M, Laine J, Simell O (2002) Cellular distribution and contribution of cyclooxygenase (COX)-2 to diabetogenesis in NOD mouse. Cell Tissue Res 310:169-175
8. Papafili A, Hill MR, Brull DJ, McAnulty RJ, Marshall RP, Humphries SE, Laurent GJ (2002) Common promoter variant in cyclooxygenase-2 represses gene expression: Evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol 22:1631-1636
9. Pickup JC, Crook MA (1998) Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41:1241-1248
10. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327-334
11. Robertson RP (1998) Dominance of cyclooxygenase-2 in the regulation of pancreatic islet prostaglandin synthesis. Diabetes 47: 1379-1383
12. Robertson RP, Chen M (1977) A role for prostaglandin E in defective insulin secretion and carbohydrate intolerance in diabetes mellitus. J Clin Invest 60:747-753
13. Robertson RP, Gavareski DJ, Porte D Jr, Bierman EL (1974) Inhibition of in vivo insulin secretion by prostaglandin E1. J Clin Invest 54:310-315
14. Schlosser W, Schlosser S, Ramadani M, Gansauge F, Gansauge S, Beger HG (2002) Cyclooxygenase-2 is overexpressed in chronic pancreatitis. Pancreas 25:26-30
15. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G (1999) Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): A cohort study. Lancet 353:1649-1652
16. Smith WL, Dewitt DL (1996) Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol 62:167-215
17. Tazawa R, Xu XM, Wu KK, Wang LH (1994) Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene. Biochem Biophys Res Commun 203: 190-199
18. Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA (2002) High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51:455-461
19. Wolford JK, Konheim YL, Colligan PB, Bogardus C (2003) Association of a F479L variant in the cytosolic phospholipase A2 gene (PLA2G4A) with decreased glucose turnover and oxidation rate in Pima Indians. Mol Genet Metabol 79:61-66
20. Xu Q, Ji YS, Schmedtje JF Jr (2000) Sp1 increases expression of cyclooxygenase-2 in hypoxic vascular endothelium. Implications of aortic aneurysm and heart failure. J Biol Chem 275:24583-24589
21. Zeger SL, Liang KY (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121-130